Healthy adults
Conditions
Interventions
Take 4 capsules of test food t.i.d.
Take 4 capsules of placebo t.i.d.
Sponsors
IMEQRD Co., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Age:50 to 69 years old 2.Gender:Women 3.Healthy adults (We define "healthy adults" as those who currently have neither severe organ damage nor a particular disease, who currently do not receive treatment associated with those disorders, and who currently do not receive any kind of drug treatment. We judge whether or not a candidate meets this definition according to the self-report submitted when a clinical trial is commenced) 4.Postmenopausal women 5.Those who can give their written informed consent
Exclusion criteria
Exclusion criteria: 1.Those who currently receive continuous drug treatment (except for drugs that are taken as needed) 2.Those who currently undergo dietary or exercise therapy under the direction of physicians 3.Those with a past medical history of any of the following: hepatic disease, severe disorder (kidney, endocrine, cardiovascular, gastrointestinal, and lung diseases, and blood and metabolic disorders), or complications 4.Those with a past medical history of mental disorder (such as depression) 5.Those with a past and current medical history of drug or food allergy 6.Those who work night shifts or irregular shifts 7.Those who currently take health food and supplements (except for those who can stop taking them after they have signed an informed consent form) 8.Smokers 9.Those who currently take warfarin product (such as Warfarin, Warlin, Arefarin, Warfarin K, etc.) 10.Those who have metallic orthopedic implants 11.Those who underwent barium enema in 3 days before the commencement of this clinical trial 12.Those who have done fingernail or toenail designs on the day of a bone density test 13.Those who are participating in other clinical trials or participated in the past 1 month and then took their test products 14.Any other conditions, in the opinion of the principal investigator, those who were determined to be unsuitable for participation in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| muscle mass, bone density | — |
Secondary
| Measure | Time frame |
|---|---|
| Markers in blood (osteocalcin, TRACP-5b, BDNF, FSH, LH, estrone, HDL-C, LDL-C, TC, and TG) and urine (deoxypyridinoline), scores of Cognitrax, vital signs, QOL questionnaire (SF-36, bowel habit questionnaire) | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed